One’s about behaviour, the other about emotions. Here’s how to respond to tantrums and meltdowns without losing your cool.

Results of part 1 of the ESSENCE phase 3 trial, published in The New England Journal of Medicine, demonstrated that a greater proportion ...

Repare Therapeutics Inc. ("Repare") , a leading clinical-stage precision oncology company, today announced that it has out-licensed its discovery platforms, including certain platform and program ...

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and ...

The Melbourne-based company says it has landed one of the biggest licensing deals in Australian biotech history.

AMRA Medical, as part of a collaborative effort composed of researchers from the University of Glasgow, University Hospitals Cleveland, and Eli Lilly and Company, recently conducted a detailed ...

Researchers study the clinical outcomes of using tumor-treating fields therapy, with or without chemoradiation, in patients ...

Researchers evaluate key measures for tracking disease progression in Usher syndrome type 2–related retinal degeneration ...

A randomized trial found that interdisciplinary care models modestly improved pain and significantly reduced opioid use in ...

Results from a clinical trial suggest that semaglutide, the substance in Ozempic and Wegovy, can halt and even reverse a ...

Trained on data covering 1.5 billion years of evolution, CZI’s new generative AI model probes cellular biology across species ...

Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.